Find out about GHTC’s membership options and the benefits of becoming a member.
Sign up to receive news and updates from GHTC.
The Global Health Innovative Technology (GHIT) Fund is a Japan-based international public-private partnership fund (PPP) between the government of Japan, multiple pharmaceutical companies, the Bill & Melinda Gates Foundation, Wellcome, and the United Nations Development Programme. The GHIT Fund invests and manages an R&D portfolio of development partnerships aimed at neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases that afflict the world’s vulnerable and underserved populations. The GHIT Fund mobilizes the Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases, in collaboration with global partners.Visit https://www.ghitfund.org/
We bring together nonprofits, academic institutions, and aligned businesses that are committed to advancing health equity through innovation.